Evidence map›Paper›PMID 42036733›Full record

ArticleArtificial organs2026

Identification of Autologous Tissue Sources and Optimization of a Treatment Method for Intraoperative Manufacturing of Heart Valve Constructs.

Marvin Steitz, Mahamuda Badhon Khan, Katharina Fritsch, Alexander Breitenstein-Attach, Jana Katharina Betty Korbacher, Jordi Joaquin Modolell Y Mainou, Katrin Schrimpf, Robert Ramm, Sara Knigge, Katja Eildermann and 8 more

Abstract read
In one paragraph

Article in Artificial organs, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Marvin SteitzDepartment of Congenital Heart Disease-Pediatric Cardiology, Deutsches Herzzentrum der Charité, Berlin, Germany.ORCID https://orcid.org/0000-0002-3337-9083
Mahamuda Badhon KhanCharité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.ORCID https://orcid.org/0000-0001-5642-2219
Katharina FritschDepartment Dynamics and Transport in Quantum Materials, Helmholtz-Zentrum Berlin für Materialien und Energie GmbH, Berlin, Germany.ORCID https://orcid.org/0000-0002-6202-9859
Alexander Breitenstein-AttachDepartment of Congenital Heart Disease-Pediatric Cardiology, Deutsches Herzzentrum der Charité, Berlin, Germany.ORCID https://orcid.org/0000-0001-7006-2897
Jana Katharina Betty KorbacherCharité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.
Jordi Joaquin Modolell Y MainouDepartment of Congenital Heart Disease-Pediatric Cardiology, Deutsches Herzzentrum der Charité, Berlin, Germany.
Katrin SchrimpfCharité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.
Robert RammLower Saxony Centre for Biomedical Engineering, Implant Research and Development, University of Veterinary Medicine Hanover, Hannover, Germany.ORCID https://orcid.org/0000-0002-8556-116X
Sara KniggeLower Saxony Centre for Biomedical Engineering, Implant Research and Development, University of Veterinary Medicine Hanover, Hannover, Germany.ORCID https://orcid.org/0000-0001-7571-3775
Katja EildermannDepartment of Pediatric Cardiology and Intensive Care Medicine, Georg-August University Göttingen, Göttingen, Germany.ORCID https://orcid.org/0000-0001-7294-5140
Georg ArltDepartment of Congenital Heart Disease-Pediatric Cardiology, Deutsches Herzzentrum der Charité, Berlin, Germany.ORCID https://orcid.org/0000-0003-4216-4663
Antonia SchulzCharité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.ORCID https://orcid.org/0000-0002-9155-9509
Jonathan Frederik Sebastian KiekenapDepartment of Congenital Heart Disease-Pediatric Cardiology, Deutsches Herzzentrum der Charité, Berlin, Germany.ORCID https://orcid.org/0009-0003-0941-1199
Boris WarnackWarnack Medconsult, Untere Wenkenhofstrasse, Riehen, Switzerland.
Peter KramerCharité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.ORCID https://orcid.org/0000-0003-4780-5271
Frank EdelmannCharité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.ORCID https://orcid.org/0000-0003-4401-5936
Felix BergerDepartment of Congenital Heart Disease-Pediatric Cardiology, Deutsches Herzzentrum der Charité, Berlin, Germany.ORCID https://orcid.org/0000-0001-7881-1557
Boris SchmittDepartment of Congenital Heart Disease-Pediatric Cardiology, Deutsches Herzzentrum der Charité, Berlin, Germany.ORCID https://orcid.org/0000-0002-6987-1264

Funding

Bundesministerium für Bildung und Forschung 13GW0498HORIZON EUROPE European Innovation Council 190188598
6 · The paper itself

Abstract

introductionValvular heart disease remains a leading cause of morbidity and mortality. Current biological and mechanical heart valve prostheses have significant limitations and fail to address the patient's needs. Most of the limitations arise from the use of foreign materials, which can largely be addressed by utilizing autologous pericardial tissue. However, not all patients have usable pericardium due to previous interventions. This study investigates peritoneum as a potential alternative to pericardium and evaluates an optimized treatment method for intraoperative tissue treatment.

methodsA previously established cross-linking method was optimized and applied to pericardial and peritoneal tissues. The tissues were characterized with respect to biochemical composition, cross-linking degree, biomechanical properties, and structural organization. Furthermore, the feasibility of valve shaping was assessed, and constructs were subjected to acute hydrodynamic testing.

resultsTissue treated with the optimized cross-linking method showed high cytocompatibility and was successfully applied to peritoneal tissue. Compared to pericardium, peritoneum exhibited a higher elastin content and a looser structural organization, resulting in distinct mechanical behavior. Both tissues could be shaped into valve constructs showing adequate acute hydrodynamic behavior under the applied test conditions.

conclusionThe findings suggest that the peritoneum is a promising candidate material for further investigation as a heart valve scaffold. However, differences in microstructure and mechanical behavior highlight the need for further testing, particularly regarding long-term durability, cyclic loading behavior, and tissue remodeling capacity.

Indexed as

BioprosthesisHeart Valve ProsthesisPericardiumPeritoneumTissue EngineeringTissue ScaffoldsAnimalsHumansMaterials TestingProsthesis DesignSwineautologousbiomaterialscardiologypericardiumperitoneum

Identifiers

PMID42036733
PMCPMC13525234

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.